DB Fitzpatrick & Co, Inc
- SEC CIK
- 0001885767
- Latest filing
- Jul 16, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by DB Fitzpatrick & Co, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 18,076
- Value
- $1.64M
- % of portfolio
- 1.3%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 18,076 | $1.64M | 1.3% | −292−1.6% | Reduced | Holders |
| Q1 2026 | 18,368 | $1.47M | 1.3% | +412+2.3% | Added | Holders |
| Q4 2025 | 17,956 | $1.53M | 1.4% | −181−1.0% | Reduced | Holders |
| Q3 2025 | 18,137 | $1.41M | 1.3% | −382−2.1% | Reduced | Holders |
| Q2 2025 | 18,519 | $1.45M | 1.3% | +67+0.4% | Added | Holders |
| Q1 2025 | 18,452 | $1.34M | 1.3% | −2,082−10.1% | Reduced | Holders |
| Q4 2024 | 20,534 | $1.52M | 1.4% | −472−2.2% | Reduced | Holders |
| Q3 2024 | 21,006 | $1.39M | 1.2% | +66+0.3% | Added | Holders |
| Q2 2024 | 20,940 | $1.93M | 1.8% | −154−0.7% | Reduced | Holders |
| Q1 2024 | 21,094 | $2.02M | 1.8% | +57+0.3% | Added | Holders |
| Q4 2023 | 21,037 | $1.60M | 1.5% | +3,213+18.0% | Added | Holders |
| Q3 2023 | 17,824 | $1.23M | 1.3% | +67+0.4% | Added | Holders |
| Q2 2023 | 17,757 | $1.68M | 1.8% | −911−4.9% | Reduced | Holders |
| Q1 2023 | 18,668 | $1.54M | 1.7% | +1,062+6.0% | Added | Holders |
| Q4 2022 | 17,606 | $1.31M | 1.5% | +5,196+41.9% | Added | Holders |
| Q3 2022 | 12,410 | $1.02M | 1.2% | −1,407−10.2% | Reduced | Holders |
| Q2 2022 | 13,817 | $1.31M | 1.4% | +527+4.0% | Added | Holders |
| Q1 2022 | 13,290 | $1.56M | 1.6% | +300+2.3% | Added | Holders |
| Q4 2021 | 12,990 | $1.68M | 1.6% | – | No prior filing | Holders |